Immunis, Inc. — Form D
Immunis, Inc. of Irvine, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-01. The offering totals $20.0M, of which $15.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-07-01
- Form: D
- Accession: 0002028798-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $15.8M
- Remaining: $4.2M
- Investors: 18
- Date of first sale: 2024-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-517540
Issuer
- Name: Immunis, Inc.
- CIK: 0002028798
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 18301 Von Karman Avenue Suite 350, Irvine, CA, 92612
- Phone: (949) 266-2501
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Gabriel Nistor | Executive Officer | Irvine, CA |
| Gabriel Nistor | Related Person | Irvine, CA |
| Takahide Koda | Director | Irvine, CA |
| Takahide Koda | Related Person | Irvine, CA |
| Hans Keirstead | Director | Irvine, CA |
| Hans Keirstead | Executive Officer | Irvine, CA |
| Hans Keirstead | Related Person | Irvine, CA |
| Daniel Kraft | Director | Irvine, CA |
| Daniel Kraft | Related Person | Irvine, CA |
Other filings by this issuer (2)
More